BE645047A - - Google Patents

Info

Publication number
BE645047A
BE645047A BE645047DA BE645047A BE 645047 A BE645047 A BE 645047A BE 645047D A BE645047D A BE 645047DA BE 645047 A BE645047 A BE 645047A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE645047A publication Critical patent/BE645047A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
BE645047D 1963-03-12 1964-03-11 BE645047A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9762/63A GB1015251A (en) 1963-03-12 1963-03-12 Aqueous pharmaceutical compositions in capsule form

Publications (1)

Publication Number Publication Date
BE645047A true BE645047A (bg) 1964-07-01

Family

ID=9878297

Family Applications (1)

Application Number Title Priority Date Filing Date
BE645047D BE645047A (bg) 1963-03-12 1964-03-11

Country Status (5)

Country Link
US (1) US3376199A (bg)
BE (1) BE645047A (bg)
DE (1) DE1467907C3 (bg)
FR (1) FR3922M (bg)
GB (1) GB1015251A (bg)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544612A2 (en) * 1991-11-25 1993-06-02 The Nisshin Oil Mills, Ltd. Composition comprising an immunogen and a triglyceride

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU1385197A (en) * 1996-01-30 1997-08-22 Zeneca Limited Packaged agrochemical composition
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
PT2279729T (pt) * 2003-07-17 2016-09-22 Banner Life Sciences Llc Preparações de libertação controlada
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US20070172965A1 (en) * 2006-01-23 2007-07-26 Kangguo Cheng Non-destructive trench volume determination and trench capacitance projection
JP5372525B2 (ja) * 2006-03-03 2013-12-18 エフ エム シー コーポレーション カプセルの製造方法および該製造方法により製造されるカプセル
EA016455B1 (ru) * 2006-10-24 2012-05-30 Хелсинн Хелткэр С.А. Мягкие капсулы, содержащие палоносетрона гидрохлорид, имеющие улучшенную стабильность и биологическую доступность
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
BR112012005453B1 (pt) * 2009-09-10 2019-09-24 DuPont Nutrition USA, Inc. Cápsula sem costura, e, método para preparar uma cápsula de alginato sem costura
CN111867567A (zh) * 2018-02-26 2020-10-30 R·P·舍勒科技有限责任公司 二甲硅油和洛哌丁胺的乳剂的药物剂型
GB202109464D0 (en) 2021-06-30 2021-08-11 Norwegian Univ Sci & Tech Ntnu Soft gel capsule

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126321A (en) * 1964-03-24 Table vii
US2183053A (en) * 1936-12-03 1939-12-12 Atlantic Coast Fisheries Co Vitamin preparation and method of making same
US2314527A (en) * 1940-07-06 1943-03-23 Atlantic Coast Fisheries Co Method of making sealed capsules
US2780355A (en) * 1953-11-09 1957-02-05 Scherer Corp R P Gelatin capsule containing water soluble substances
US2946724A (en) * 1957-05-29 1960-07-26 American Cyanamid Co Stable poliomyelitis live virus vaccine
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine
US3099601A (en) * 1959-10-02 1963-07-30 Anchor Serum Company Bacterin in aqueous polyethylene, mineral oil emulsion
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3185625A (en) * 1961-11-08 1965-05-25 Brown Ethan Allan Injectionable substances

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544612A2 (en) * 1991-11-25 1993-06-02 The Nisshin Oil Mills, Ltd. Composition comprising an immunogen and a triglyceride
EP0544612A3 (en) * 1991-11-25 1994-08-10 Nisshin Oil Mills Ltd Composition comprising an immunogen and a triglyceride

Also Published As

Publication number Publication date
DE1467907C3 (de) 1973-09-27
US3376199A (en) 1968-04-02
GB1015251A (en) 1965-12-31
DE1467907B2 (de) 1973-03-08
FR3922M (bg) 1966-02-14
DE1467907A1 (de) 1969-01-23

Similar Documents

Publication Publication Date Title
AR142945A1 (bg)
FR3922M (bg)
AT260747B (bg)
BE626590A (bg)
BE642065A (bg)
BE31062A (bg)
BE462764A (bg)
BE465565A (bg)
BE507458A (bg)
BE533484A (bg)
BE547422A (bg)
BE571209A (bg)
BE582314A (bg)
BE625825A (bg)
BE603935A (bg)
BE608372A (bg)
BE612803A (bg)
BE614220A (bg)
BE616247A (bg)
BE616830A (bg)
BE626803A (bg)
BE645782A (bg)
BE645068A (bg)
BE644847A (bg)
BE616967A (bg)